AAT Bioquest

Citation Explorer

Search citations by product catalog number:

There are 3 citation(s) for Live or Dead™ Fixable Dead Cell Staining Kit *Blue Fluorescence* (Cat No. 22600).

Autophagy proteins are not universally required for phagosome maturation
Authors: Cemma, Marija and Grinstein, Sergio and Brumell, John H
Journal: Autophagy (2016): 1440--1446
Differential detection of tumor cells using a combination of cell rolling, multivalent binding, and multiple antibodies
Authors: Myung, Ja Hye and Gajjar, Khyati A and Chen, Jihua and Molokie, Robert E and Hong, Seungpyo
Journal: Analytical chemistry (2014): 6088--6094
Versatile fabrication of nanoscale sol--gel bioactive glass particles for efficient bone tissue regeneration
Authors: Lei, Bo and Chen, Xiaofeng and Han, Xue and Zhou, Jiaan
Journal: Journal of Materials Chemistry (2012): 16906--16913

There are 26 reference(s) for Live or Dead™ Fixable Dead Cell Staining Kit *Blue Fluorescence* (Cat No. 22600).

Requirements, features, and performance of high content screening platforms
Authors: Gough AH, Johnston PA.
Journal: Methods Mol Biol (2007): 41
A pharmaceutical company user's perspective on the potential of high content screening in drug discovery
Authors: Hoffman AF, Garippa RJ.
Journal: Methods Mol Biol (2007): 19
Optimizing the integration of immunoreagents and fluorescent probes for multiplexed high content screening assays
Authors: Giuliano KA., undefined
Journal: Methods Mol Biol (2007): 189
Past, present, and future of high content screening and the field of cellomics
Authors: Taylor DL., undefined
Journal: Methods Mol Biol (2007): 3
High-content fluorescence-based screening for epigenetic modulators
Authors: Martinez ED, Dull AB, Beutler JA, Hager GL.
Journal: Methods Enzymol (2006): 21
Application of laser-scanning fluorescence microplate cytometry in high content screening
Authors: Bowen WP, Wylie PG.
Journal: Assay Drug Dev Technol (2006): 209
High-content screening of known G protein-coupled receptors by arrestin translocation
Authors: Hudson CC, Oakley RH, Sjaastad MD, Loomis CR.
Journal: Methods Enzymol (2006): 63
Evaluation of a high-content screening fluorescence-based assay analyzing the pharmacological modulation of lipid homeostasis in human macrophages
Authors: Werner T, Liebisch G, Gr and l M, Schmitz G.
Journal: Cytometry A (2006): 200
Automated high content screening for phosphoinositide 3 kinase inhibition using an AKT 1 redistribution assay
Authors: Wolff M, Haasen D, Merk S, Kroner M, Maier U, Bordel S, Wiedenmann J, Nienhaus GU, Valler M, Heilker R.
Journal: Comb Chem High Throughput Screen (2006): 339
High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening
Authors: O'Brien P J, Irwin W, Diaz D, Howard-Cofield E, Krejsa CM, Slaughter MR, Gao B, Kaludercic N, Angeline A, Bernardi P, Brain P, Hougham C.
Journal: Arch Toxicol (2006): 580
G protein-coupled receptor internalization assays in the high-content screening format
Authors: Haasen D, Schnapp A, Valler MJ, Heilker R.
Journal: Methods Enzymol (2006): 121
Novel fluorescent proteins for high-content screening
Authors: Wolff M, Wiedenmann J, Nienhaus GU, Valler M, Heilker R.
Journal: Drug Discov Today (2006): 1054
High-content screening: emerging hardware and software technologies
Authors: Lee S, Howell BJ.
Journal: Methods Enzymol (2006): 468
Quantitative cell-based high-content screening for vasopressin receptor agonists using transfluor technology
Authors: Ghosh RN, DeBiasio R, Hudson CC, Ramer ER, Cowan CL, Oakley RH.
Journal: J Biomol Screen (2005): 476
High content screening for G protein-coupled receptors using cell-based protein translocation assays
Authors: Granas C, Lundholt BK, Heydorn A, Linde V, Pedersen HC, Krog-Jensen C, Rosenkilde MM, Pagliaro L.
Journal: Comb Chem High Throughput Screen (2005): 301
Inflammatory pathway analysis using a high content screening platform
Authors: Bertelsen M, Sanfridson A.
Journal: Assay Drug Dev Technol (2005): 261
High-content screening assay for activators of the Wnt/Fzd pathway in primary human cells
Authors: Borchert KM, Galvin RJ, Frolik CA, Hale LV, Halladay DL, Gonyier RJ, Trask OJ, Nickischer DR, Houck KA.
Journal: Assay Drug Dev Technol (2005): 133
High-content screening with siRNA optimizes a cell biological approach to drug discovery: defining the role of P53 activation in the cellular response to anticancer drugs
Authors: Giuliano KA, Chen YT, Taylor DL.
Journal: J Biomol Screen (2004): 557
A quantitative cell-based high-content screening assay for the epidermal growth factor receptor-specific activation of mitogen-activated protein kinase
Authors: Ghosh RN, Grove L, Lapets O.
Journal: Assay Drug Dev Technol (2004): 473
Flow cytometry for high-throughput, high-content screening
Authors: Edwards BS, Oprea T, Prossnitz ER, Sklar LA.
Journal: Curr Opin Chem Biol (2004): 392
siRNA cell arrays for high-content screening microscopy
Authors: Erfle H, Simpson JC, Bastiaens PI, Pepperkok R.
Journal: Biotechniques (2004): 454
Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScan high-content screening reader
Authors: Gasparri F, Mariani M, Sola F, Galvani A.
Journal: J Biomol Screen (2004): 232
Cell-active dual specificity phosphatase inhibitors identified by high-content screening
Authors: Vogt A, Cooley KA, Brisson M, Tarpley MG, Wipf P, Lazo JS.
Journal: Chem Biol (2003): 733
Advances in high content screening for drug discovery
Authors: Giuliano KA, Haskins JR, Taylor DL.
Journal: Assay Drug Dev Technol (2003): 565
The use of biosensors to study GPCR function: applications for high-content screening
Authors: Conway BR, Demarest KT.
Journal: Receptors Channels (2002): 331
Fluorescence imaging and engineered biosensors: functional and activity-based sensing using high content screening
Authors: Kapur R., undefined
Journal: Ann N Y Acad Sci (2002): 196